BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 22847008)

  • 1. Role of p63 in Development, Tumorigenesis and Cancer Progression.
    Bergholz J; Xiao ZX
    Cancer Microenviron; 2012 Dec; 5(3):311-22. PubMed ID: 22847008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
    Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
    Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63.
    Helton ES; Zhang J; Chen X
    Oncogene; 2008 May; 27(20):2843-50. PubMed ID: 18037962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-binding and transactivation activities are essential for TAp63 protein degradation.
    Ying H; Chang DL; Zheng H; McKeon F; Xiao ZX
    Mol Cell Biol; 2005 Jul; 25(14):6154-64. PubMed ID: 15988026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
    Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
    J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress Responses.
    Napoli M; Deshpande AA; Chakravarti D; Rajapakshe K; Gunaratne PH; Coarfa C; Flores ER
    Cancer Res Commun; 2024 Feb; 4(2):264-278. PubMed ID: 38165157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dual role of p63 in cancer.
    Xu Y; Yang X; Xiong Q; Han J; Zhu Q
    Front Oncol; 2023; 13():1116061. PubMed ID: 37182132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of p63 in epidermal development and tumorigenesis.
    Yao JY; Chen JK
    Biomed J; 2012; 35(6):457-63. PubMed ID: 23442358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System.
    Armstrong SR; Wu H; Wang B; Abuetabh Y; Sergi C; Leng RP
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27929429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAp63 induces senescence and suppresses tumorigenesis in vivo.
    Guo X; Keyes WM; Papazoglu C; Zuber J; Li W; Lowe SW; Vogel H; Mills AA
    Nat Cell Biol; 2009 Dec; 11(12):1451-7. PubMed ID: 19898465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p63 is the molecular switch for initiation of an epithelial stratification program.
    Koster MI; Kim S; Mills AA; DeMayo FJ; Roop DR
    Genes Dev; 2004 Jan; 18(2):126-31. PubMed ID: 14729569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation.
    Wu HH; Wang B; Armstrong SR; Abuetabh Y; Leng S; Roa WHY; Atfi A; Marchese A; Wilson B; Sergi C; Flores ER; Eisenstat DD; Leng RP
    Nucleic Acids Res; 2021 Mar; 49(5):2740-2758. PubMed ID: 33619536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas.
    Chen YK; Hsue SS; Lin LM
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63.
    Helton ES; Zhu J; Chen X
    J Biol Chem; 2006 Feb; 281(5):2533-42. PubMed ID: 16319057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible Usage of p63 in Bioptic Diagnostics.
    Galoczová M; Nenutil R; Coates P; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):27-31. PubMed ID: 31023021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent alteration of p63 expression in human primary bladder carcinomas.
    Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
    Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors.
    Vakonaki E; Soulitzis N; Sifakis S; Papadogianni D; Koutroulakis D; Spandidos DA
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1271-8. PubMed ID: 22441934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma.
    Herfs M; Hubert P; Suarez-Carmona M; Reschner A; Saussez S; Berx G; Savagner P; Boniver J; Delvenne P
    Am J Pathol; 2010 Apr; 176(4):1941-9. PubMed ID: 20150431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of p63 expression in primary and immortalized nasopharyngeal epithelial cells.
    Yip YL; Tsao SW
    Int J Oncol; 2008 Oct; 33(4):713-24. PubMed ID: 18813784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connecting p63 to cellular proliferation: the example of the adenosine deaminase target gene.
    Sbisà E; Mastropasqua G; Lefkimmiatis K; Caratozzolo MF; D'Erchia AM; Tullo A
    Cell Cycle; 2006 Jan; 5(2):205-12. PubMed ID: 16410722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.